These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17287426)

  • 1. Insulin induces renal vasodilation, increases plasma renin activity, and sensitizes the renal vasculature to angiotensin receptor blockade in healthy subjects.
    Perlstein TS; Gerhard-Herman M; Hollenberg NK; Williams GH; Thomas A
    J Am Soc Nephrol; 2007 Mar; 18(3):944-51. PubMed ID: 17287426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic interruption of the renin-angiotensin system and the kidney: differential responses to angiotensin-converting enzyme and renin inhibition.
    Hollenberg NK
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S239-42. PubMed ID: 9892171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
    Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
    J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal response to angiotensin II is blunted in sodium-sensitive normotensive men.
    Visser FW; Boonstra AH; Titia Lely A; Boomsma F; Navis G
    Am J Hypertens; 2008 Mar; 21(3):323-8. PubMed ID: 18219299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
    Wong PC; Zimmerman BG; Kraft E; Kounenis G; Friedman P
    J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular oxidative stress is associated with insulin resistance in hyper-reninemic nonmodulating essential hypertension.
    Sanchez R; Fischer P; Cuniberti L; Masnatta LD; Ramírez AJ
    J Hypertens; 2007 Dec; 25(12):2434-40. PubMed ID: 17984665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low birth weight in response to salt restriction during pregnancy is not due to alterations in uterine-placental blood flow or the placental and peripheral renin-angiotensin system.
    Leandro SM; Furukawa LN; Shimizu MH; Casarini DE; Seguro AC; Patriarca G; Coelho MS; Dolnikoff MS; Heimann JC
    Physiol Behav; 2008 Sep; 95(1-2):145-51. PubMed ID: 18572207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans.
    Watanabe S; Tagawa T; Yamakawa K; Shimabukuro M; Ueda S
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2376-80. PubMed ID: 16179595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma renin activity and insulin sensitivity in normotensive subjects.
    Townsend RR; Zhao H
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):894-8. PubMed ID: 7826552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kidney is resistant to chronic hypoglycaemia in late-gestation fetal sheep.
    Boyce AC; Gibson KJ; Wintour EM; Koukoulas I; Gatford KL; Owens JA; Lumbers ER
    Can J Physiol Pharmacol; 2007 Jun; 85(6):597-605. PubMed ID: 17823621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.
    Patel TV; Williams GH; Fisher ND
    J Hypertens; 2008 Jul; 26(7):1353-9. PubMed ID: 18551010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
    Hollenberg NK; Williams GH
    Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute elevation of plasma non-esterified fatty acids increases pulse wave velocity and induces peripheral vasodilation in humans in vivo.
    Riksen NP; Bosselaar M; Bakker SJ; Heine RJ; Rongen GA; Tack CJ; Smits P
    Clin Sci (Lond); 2007 Jul; 113(1):33-40. PubMed ID: 17309447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the renin-angiotensin system improves insulin sensitivity in thermal injury.
    Kasper SO; Castle SM; Daley BJ; Enderson BL; Karlstad MD
    Shock; 2006 Nov; 26(5):485-8. PubMed ID: 17047519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
    Weir MR
    J Hum Hypertens; 2007 Oct; 21(10):770-9. PubMed ID: 17597800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.